APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

HIV Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global HIV Drugs Market Analysis and Forecast 2026-2032

Report ID 173998790222 December 2025198 pages

Choose your research edition.

Industry ResearchHIV Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal HIV Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global HIV Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HIV Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HIV Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HIV Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HIV Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of HIV Drugs include Johnson & Johnson, Merck, GlaxoSmithKline, Gilead Sciences and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for HIV Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HIV Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for HIV Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HIV Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HIV Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for HIV Drugs sales, projected growth trends, production technology, application and end-user industry.

HIV Drugs Segment by Company

Johnson & Johnson

Merck

GlaxoSmithKline

Gilead Sciences

Bristol-Myers Squibb

HIV Drugs Segment by Type

Fusion Inhibitors

Entry Inhibitors - CCR5 Co-Receptor Antagonist

Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Multi-Class Combination Products

Protease Inhibitors

HIV Integrase Strand Transfer Inhibitors

HIV Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Others

HIV Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of HIV Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of HIV Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HIV Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fusion Inhibitors Major Manufacturers Table 3. Entry Inhibitors - CCR5 Co-Receptor Antagonist Major Manufacturers Table 4. Nucleoside Reverse Transcriptase Inhibitors Major Manufacturers Table 5. Non-Nucleoside Reverse Transcriptase Inhibitors Major Manufacturers Table 6. Multi-Class Combination Products Major Manufacturers Table 7. Protease Inhibitors Major Manufacturers Table 8. HIV Integrase Strand Transfer Inhibitors Major Manufacturers Table 9. Global HIV Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Online Pharmacies Major Manufacturers Table 11. Hospital Pharmacies Major Manufacturers Table 12. Retail Pharmacies Major Manufacturers Table 13. Others Major Manufacturers Table 14. HIV Drugs Industry Trends Table 15. HIV Drugs Industry Drivers Table 16. HIV Drugs Industry Opportunities and Challenges Table 17. HIV Drugs Industry Restraints Table 18. Global HIV Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global HIV Drugs Revenue by Region (2021-2026) & (US$ Million) Table 20. Global HIV Drugs Revenue by Region (2027-2032) & (US$ Million) Table 21. Global HIV Drugs Revenue Market Share by Region (2021-2026) Table 22. Global HIV Drugs Revenue Market Share by Region (2027-2032) Table 23. Global HIV Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 24. Global HIV Drugs Sales by Region (2021-2026) & (k units) Table 25. Global HIV Drugs Sales by Region (2027-2032) & (k units) Table 26. Global HIV Drugs Sales Market Share by Region (2021-2026) Table 27. Global HIV Drugs Sales Market Share by Region (2027-2032) Table 28. Global HIV Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global HIV Drugs Revenue Market Share by Manufacturers (2021-2026) Table 30. Global HIV Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global HIV Drugs Sales Market Share by Manufacturers (2021-2026) Table 32. Global HIV Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 33. Global HIV Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global HIV Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global HIV Drugs Manufacturers, Product Type & Application Table 36. Global HIV Drugs Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global HIV Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global HIV Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global HIV Drugs Revenue by Type (2021-2026) & (US$ Million) Table 41. Global HIV Drugs Revenue by Type (2027-2032) & (US$ Million) Table 42. Global HIV Drugs Revenue Market Share by Type (2021-2026) Table 43. Global HIV Drugs Revenue Market Share by Type (2027-2032) Table 44. Global HIV Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 45. Global HIV Drugs Sales by Type (2021-2026) & (k units) Table 46. Global HIV Drugs Sales by Type (2027-2032) & (k units) Table 47. Global HIV Drugs Sales Market Share by Type (2021-2026) Table 48. Global HIV Drugs Sales Market Share by Type (2027-2032) Table 49. Global HIV Drugs Price by Type (2021-2026) & (US$/unit) Table 50. Global HIV Drugs Price by Type (2027-2032) & (US$/unit) Table 51. Global HIV Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global HIV Drugs Revenue by Application (2021-2026) & (US$ Million) Table 53. Global HIV Drugs Revenue by Application (2027-2032) & (US$ Million) Table 54. Global HIV Drugs Revenue Market Share by Application (2021-2026) Table 55. Global HIV Drugs Revenue Market Share by Application (2027-2032) Table 56. Global HIV Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 57. Global HIV Drugs Sales by Application (2021-2026) & (k units) Table 58. Global HIV Drugs Sales by Application (2027-2032) & (k units) Table 59. Global HIV Drugs Sales Market Share by Application (2021-2026) Table 60. Global HIV Drugs Sales Market Share by Application (2027-2032) Table 61. Global HIV Drugs Price by Application (2021-2026) & (US$/unit) Table 62. Global HIV Drugs Price by Application (2027-2032) & (US$/unit) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson HIV Drugs Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck HIV Drugs Product Portfolio Table 72. Merck Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline HIV Drugs Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. Gilead Sciences Company Information Table 79. Gilead Sciences Business Overview Table 80. Gilead Sciences HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Gilead Sciences HIV Drugs Product Portfolio Table 82. Gilead Sciences Recent Development Table 83. Bristol-Myers Squibb Company Information Table 84. Bristol-Myers Squibb Business Overview Table 85. Bristol-Myers Squibb HIV Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Bristol-Myers Squibb HIV Drugs Product Portfolio Table 87. Bristol-Myers Squibb Recent Development Table 88. North America HIV Drugs Revenue by Type (2021-2026) & (US$ Million) Table 89. North America HIV Drugs Revenue by Type (2027-2032) & (US$ Million) Table 90. North America HIV Drugs Sales by Type (2021-2026) & (k units) Table 91. North America HIV Drugs Sales by Type (2027-2032) & (k units) Table 92. North America HIV Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 93. North America HIV Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 94. North America HIV Drugs Revenue by Application (2021-2026) & (US$ Million) Table 95. North America HIV Drugs Revenue by Application (2027-2032) & (US$ Million) Table 96. North America HIV Drugs Sales by Application (2021-2026) & (k units) Table 97. North America HIV Drugs Sales by Application (2027-2032) & (k units) Table 98. North America HIV Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 99. North America HIV Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 100. North America HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America HIV Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America HIV Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America HIV Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 104. North America HIV Drugs Sales by Country (2021-2026) & (k units) Table 105. North America HIV Drugs Sales by Country (2027-2032) & (k units) Table 106. North America HIV Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 107. North America HIV Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 108. United States HIV Drugs Revenue (2021-2032) & (US$ Million) Table 109. Canada HIV Drugs Revenue (2021-2032) & (US$ Million) Table 110. Mexico HIV Drugs Revenue (2021-2032) & (US$ Million) Table 111. Europe HIV Drugs Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe HIV Drugs Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe HIV Drugs Sales by Type (2021-2026) & (k units) Table 114. Europe HIV Drugs Sales by Type (2027-2032) & (k units) Table 115. Europe HIV Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 116. Europe HIV Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 117. Europe HIV Drugs Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe HIV Drugs Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe HIV Drugs Sales by Application (2021-2026) & (k units) Table 120. Europe HIV Drugs Sales by Application (2027-2032) & (k units) Table 121. Europe HIV Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 122. Europe HIV Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 123. Europe HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe HIV Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe HIV Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe HIV Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 127. Europe HIV Drugs Sales by Country (2021-2026) & (k units) Table 128. Europe HIV Drugs Sales by Country (2027-2032) & (k units) Table 129. Europe HIV Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 130. Europe HIV Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 131. Germany HIV Drugs Revenue (2021-2032) & (US$ Million) Table 132. France HIV Drugs Revenue (2021-2032) & (US$ Million) Table 133. U.K. HIV Drugs Revenue (2021-2032) & (US$ Million) Table 134. Italy HIV Drugs Revenue (2021-2032) & (US$ Million) Table 135. Russia HIV Drugs Revenue (2021-2032) & (US$ Million) Table 136. Spain HIV Drugs Revenue (2021-2032) & (US$ Million) Table 137. Netherlands HIV Drugs Revenue (2021-2032) & (US$ Million) Table 138. Switzerland HIV Drugs Revenue (2021-2032) & (US$ Million) Table 139. Sweden HIV Drugs Revenue (2021-2032) & (US$ Million) Table 140. Poland HIV Drugs Revenue (2021-2032) & (US$ Million) Table 141. China HIV Drugs Revenue by Type (2021-2026) & (US$ Million) Table 142. China HIV Drugs Revenue by Type (2027-2032) & (US$ Million) Table 143. China HIV Drugs Sales by Type (2021-2026) & (k units) Table 144. China HIV Drugs Sales by Type (2027-2032) & (k units) Table 145. China HIV Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 146. China HIV Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 147. China HIV Drugs Revenue by Application (2021-2026) & (US$ Million) Table 148. China HIV Drugs Revenue by Application (2027-2032) & (US$ Million) Table 149. China HIV Drugs Sales by Application (2021-2026) & (k units) Table 150. China HIV Drugs Sales by Application (2027-2032) & (k units) Table 151. China HIV Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 152. China HIV Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 153. Asia HIV Drugs Revenue by Type (2021-2026) & (US$ Million) Table 154. Asia HIV Drugs Revenue by Type (2027-2032) & (US$ Million) Table 155. Asia HIV Drugs Sales by Type (2021-2026) & (k units) Table 156. Asia HIV Drugs Sales by Type (2027-2032) & (k units) Table 157. Asia HIV Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 158. Asia HIV Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 159. Asia HIV Drugs Revenue by Application (2021-2026) & (US$ Million) Table 160. Asia HIV Drugs Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia HIV Drugs Sales by Application (2021-2026) & (k units) Table 162. Asia HIV Drugs Sales by Application (2027-2032) & (k units) Table 163. Asia HIV Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 164. Asia HIV Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 165. Asia HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia HIV Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Asia HIV Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Asia HIV Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. Asia HIV Drugs Sales by Country (2021-2026) & (k units) Table 170. Asia HIV Drugs Sales by Country (2027-2032) & (k units) Table 171. Asia HIV Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 172. Asia HIV Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 173. Japan HIV Drugs Revenue (2021-2032) & (US$ Million) Table 174. South Korea HIV Drugs Revenue (2021-2032) & (US$ Million) Table 175. India HIV Drugs Revenue (2021-2032) & (US$ Million) Table 176. Australia HIV Drugs Revenue (2021-2032) & (US$ Million) Table 177. Taiwan HIV Drugs Revenue (2021-2032) & (US$ Million) Table 178. Southeast Asia HIV Drugs Revenue (2021-2032) & (US$ Million) Table 179. SAMEA HIV Drugs Revenue by Type (2021-2026) & (US$ Million) Table 180. SAMEA HIV Drugs Revenue by Type (2027-2032) & (US$ Million) Table 181. SAMEA HIV Drugs Sales by Type (2021-2026) & (k units) Table 182. SAMEA HIV Drugs Sales by Type (2027-2032) & (k units) Table 183. SAMEA HIV Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 184. SAMEA HIV Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 185. SAMEA HIV Drugs Revenue by Application (2021-2026) & (US$ Million) Table 186. SAMEA HIV Drugs Revenue by Application (2027-2032) & (US$ Million) Table 187. SAMEA HIV Drugs Sales by Application (2021-2026) & (k units) Table 188. SAMEA HIV Drugs Sales by Application (2027-2032) & (k units) Table 189. SAMEA HIV Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 190. SAMEA HIV Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 191. SAMEA HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. SAMEA HIV Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. SAMEA HIV Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. SAMEA HIV Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 195. SAMEA HIV Drugs Sales by Country (2021-2026) & (k units) Table 196. SAMEA HIV Drugs Sales by Country (2027-2032) & (k units) Table 197. SAMEA HIV Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 198. SAMEA HIV Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 199. Brazil HIV Drugs Revenue (2021-2032) & (US$ Million) Table 200. Argentina HIV Drugs Revenue (2021-2032) & (US$ Million) Table 201. Chile HIV Drugs Revenue (2021-2032) & (US$ Million) Table 202. Colombia HIV Drugs Revenue (2021-2032) & (US$ Million) Table 203. Peru HIV Drugs Revenue (2021-2032) & (US$ Million) Table 204. Saudi Arabia HIV Drugs Revenue (2021-2032) & (US$ Million) Table 205. Israel HIV Drugs Revenue (2021-2032) & (US$ Million) Table 206. UAE HIV Drugs Revenue (2021-2032) & (US$ Million) Table 207. Turkey HIV Drugs Revenue (2021-2032) & (US$ Million) Table 208. Iran HIV Drugs Revenue (2021-2032) & (US$ Million) Table 209. Egypt HIV Drugs Revenue (2021-2032) & (US$ Million) Table 210. Key Raw Materials Table 211. Raw Materials Key Suppliers Table 212. HIV Drugs Distributors List Table 213. HIV Drugs Customers List Table 214. Research Programs/Design for This Report Table 215. Authors List of This Report Table 216. Secondary Sources Table 217. Primary Sources List of Figures Figure 1. HIV Drugs Image Figure 2. Global HIV Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HIV Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fusion Inhibitors Image Figure 5. Entry Inhibitors - CCR5 Co-Receptor Antagonist Image Figure 6. Nucleoside Reverse Transcriptase Inhibitors Image Figure 7. Non-Nucleoside Reverse Transcriptase Inhibitors Image Figure 8. Multi-Class Combination Products Image Figure 9. Protease Inhibitors Image Figure 10. HIV Integrase Strand Transfer Inhibitors Image Figure 11. Global HIV Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global HIV Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 13. Online Pharmacies Image Figure 14. Hospital Pharmacies Image Figure 15. Retail Pharmacies Image Figure 16. Others Image Figure 17. Global HIV Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global HIV Drugs Revenue (2021-2032) & (US$ Million) Figure 19. Global HIV Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global HIV Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global HIV Drugs Revenue Market Share by Region (2021-2032) Figure 22. Global HIV Drugs Sales (2021-2032) & (k units) Figure 23. Global HIV Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 24. Global HIV Drugs Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico HIV Drugs Sales YoY (2021-2032) & (k units) Figure 26. Europe HIV Drugs Sales YoY (2021-2032) & (k units) Figure 27. China HIV Drugs Sales YoY (2021-2032) & (k units) Figure 28. Asia (Excluding China) HIV Drugs Sales YoY (2021-2032) & (k units) Figure 29. South America, Middle East and Africa HIV Drugs Sales YoY (2021-2032) & (k units) Figure 30. Global HIV Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global HIV Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global HIV Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global HIV Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global HIV Drugs Revenue Market Share by Type (2021-2032) Figure 36. Global HIV Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 37. Global HIV Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global HIV Drugs Sales Market Share by Type (2021-2032) Figure 39. Global HIV Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global HIV Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global HIV Drugs Revenue Market Share by Application (2021-2032) Figure 42. Global HIV Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 43. Global HIV Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global HIV Drugs Sales Market Share by Application (2021-2032) Figure 45. North America HIV Drugs Revenue Share by Type (2021-2032) Figure 46. North America HIV Drugs Sales Share by Type (2021-2032) Figure 47. North America HIV Drugs Revenue Share by Application (2021-2032) Figure 48. North America HIV Drugs Sales Share by Application (2021-2032) Figure 49. North America HIV Drugs Revenue Share by Country (2021-2032) Figure 50. North America HIV Drugs Sales Share by Country (2021-2032) Figure 51. Europe HIV Drugs Revenue Share by Type (2021-2032) Figure 52. Europe HIV Drugs Sales Share by Type (2021-2032) Figure 53. Europe HIV Drugs Revenue Share by Application (2021-2032) Figure 54. Europe HIV Drugs Sales Share by Application (2021-2032) Figure 55. Europe HIV Drugs Revenue Share by Country (2021-2032) Figure 56. Europe HIV Drugs Sales Share by Country (2021-2032) Figure 57. China HIV Drugs Revenue Share by Type (2021-2032) Figure 58. China HIV Drugs Sales Share by Type (2021-2032) Figure 59. China HIV Drugs Revenue Share by Application (2021-2032) Figure 60. China HIV Drugs Sales Share by Application (2021-2032) Figure 61. Asia HIV Drugs Revenue Share by Type (2021-2032) Figure 62. Asia HIV Drugs Sales Share by Type (2021-2032) Figure 63. Asia HIV Drugs Revenue Share by Application (2021-2032) Figure 64. Asia HIV Drugs Sales Share by Application (2021-2032) Figure 65. Asia HIV Drugs Revenue Share by Country (2021-2032) Figure 66. Asia HIV Drugs Sales Share by Country (2021-2032) Figure 67. SAMEA HIV Drugs Revenue Share by Type (2021-2032) Figure 68. SAMEA HIV Drugs Sales Share by Type (2021-2032) Figure 69. SAMEA HIV Drugs Revenue Share by Application (2021-2032) Figure 70. SAMEA HIV Drugs Sales Share by Application (2021-2032) Figure 71. SAMEA HIV Drugs Revenue Share by Country (2021-2032) Figure 72. SAMEA HIV Drugs Sales Share by Country (2021-2032) Figure 73. HIV Drugs Value Chain Figure 74. Manufacturing Cost Structure Figure 75. HIV Drugs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Fusion Inhibitors
  • Entry Inhibitors - CCR5 Co-Receptor Antagonist
  • Nucleoside Reverse Transcriptase Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Multi-Class Combination Products
  • Protease Inhibitors
  • HIV Integrase Strand Transfer Inhibitors
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Johnson & Johnson
  • Merck
  • GlaxoSmithKline
  • Gilead Sciences
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HIV Drugs Market by Type
  3. 1.2.1 Global HIV Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fusion Inhibitors
  5. 1.2.3 Entry Inhibitors - CCR5 Co-Receptor Antagonist
  6. 1.2.4 Nucleoside Reverse Transcriptase Inhibitors
  7. 1.2.5 Non-Nucleoside Reverse Transcriptase Inhibitors
  8. 1.2.6 Multi-Class Combination Products
  9. 1.2.7 Protease Inhibitors
  10. 1.2.8 HIV Integrase Strand Transfer Inhibitors
  11. 1.3 HIV Drugs Market by Application
  12. 1.3.1 Global HIV Drugs Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Online Pharmacies
  14. 1.3.3 Hospital Pharmacies
  15. 1.3.4 Retail Pharmacies
  16. 1.3.5 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 HIV Drugs Market Dynamics
  1. 2.1 HIV Drugs Industry Trends
  2. 2.2 HIV Drugs Industry Drivers
  3. 2.3 HIV Drugs Industry Opportunities and Challenges
  4. 2.4 HIV Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global HIV Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global HIV Drugs Revenue by Region
  3. 3.2.1 Global HIV Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HIV Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global HIV Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global HIV Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global HIV Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global HIV Drugs Sales by Region
  9. 3.4.1 Global HIV Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global HIV Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global HIV Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global HIV Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global HIV Drugs Revenue by Manufacturers
  2. 4.1.1 Global HIV Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global HIV Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global HIV Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HIV Drugs Sales by Manufacturers
  6. 4.2.1 Global HIV Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global HIV Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global HIV Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global HIV Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global HIV Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global HIV Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global HIV Drugs Manufacturers, Product Type & Application
  13. 4.7 Global HIV Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global HIV Drugs Market CR5 and HHI
  16. 4.8.2 2025 HIV Drugs Tier 1, Tier 2, and Tier 3
5 HIV Drugs Market by Type
  1. 5.1 Global HIV Drugs Revenue by Type
  2. 5.1.1 Global HIV Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global HIV Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global HIV Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global HIV Drugs Sales by Type
  6. 5.2.1 Global HIV Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HIV Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global HIV Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global HIV Drugs Price by Type
6 HIV Drugs Market by Application
  1. 6.1 Global HIV Drugs Revenue by Application
  2. 6.1.1 Global HIV Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global HIV Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global HIV Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global HIV Drugs Sales by Application
  6. 6.2.1 Global HIV Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global HIV Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global HIV Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global HIV Drugs Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson HIV Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson HIV Drugs Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck HIV Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck HIV Drugs Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 GlaxoSmithKline
  14. 7.3.1 GlaxoSmithKline Company Information
  15. 7.3.2 GlaxoSmithKline Business Overview
  16. 7.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline HIV Drugs Product Portfolio
  18. 7.3.5 GlaxoSmithKline Recent Developments
  19. 7.4 Gilead Sciences
  20. 7.4.1 Gilead Sciences Company Information
  21. 7.4.2 Gilead Sciences Business Overview
  22. 7.4.3 Gilead Sciences HIV Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Gilead Sciences HIV Drugs Product Portfolio
  24. 7.4.5 Gilead Sciences Recent Developments
  25. 7.5 Bristol-Myers Squibb
  26. 7.5.1 Bristol-Myers Squibb Company Information
  27. 7.5.2 Bristol-Myers Squibb Business Overview
  28. 7.5.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bristol-Myers Squibb HIV Drugs Product Portfolio
  30. 7.5.5 Bristol-Myers Squibb Recent Developments
8 North America
  1. 8.1 North America HIV Drugs Market Size by Type
  2. 8.1.1 North America HIV Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America HIV Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America HIV Drugs Price by Type (2021-2032)
  5. 8.2 North America HIV Drugs Market Size by Application
  6. 8.2.1 North America HIV Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America HIV Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America HIV Drugs Price by Application (2021-2032)
  9. 8.3 North America HIV Drugs Market Size by Country
  10. 8.3.1 North America HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America HIV Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America HIV Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe HIV Drugs Market Size by Type
  2. 9.1.1 Europe HIV Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe HIV Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe HIV Drugs Price by Type (2021-2032)
  5. 9.2 Europe HIV Drugs Market Size by Application
  6. 9.2.1 Europe HIV Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe HIV Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe HIV Drugs Price by Application (2021-2032)
  9. 9.3 Europe HIV Drugs Market Size by Country
  10. 9.3.1 Europe HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe HIV Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe HIV Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China HIV Drugs Market Size by Type
  2. 10.1.1 China HIV Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China HIV Drugs Sales by Type (2021-2032)
  4. 10.1.3 China HIV Drugs Price by Type (2021-2032)
  5. 10.2 China HIV Drugs Market Size by Application
  6. 10.2.1 China HIV Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China HIV Drugs Sales by Application (2021-2032)
  8. 10.2.3 China HIV Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HIV Drugs Market Size by Type
  2. 11.1.1 Asia HIV Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia HIV Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia HIV Drugs Price by Type (2021-2032)
  5. 11.2 Asia HIV Drugs Market Size by Application
  6. 11.2.1 Asia HIV Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia HIV Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia HIV Drugs Price by Application (2021-2032)
  9. 11.3 Asia HIV Drugs Market Size by Country
  10. 11.3.1 Asia HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia HIV Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia HIV Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HIV Drugs Market Size by Type
  2. 12.1.1 SAMEA HIV Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA HIV Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA HIV Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA HIV Drugs Market Size by Application
  6. 12.2.1 SAMEA HIV Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA HIV Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA HIV Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA HIV Drugs Market Size by Country
  10. 12.3.1 SAMEA HIV Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA HIV Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA HIV Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 HIV Drugs Value Chain Analysis
  2. 13.1.1 HIV Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 HIV Drugs Production Mode & Process
  6. 13.2 HIV Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 HIV Drugs Distributors
  9. 13.2.3 HIV Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst